These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 12358766)
21. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. Narita M; Nagumo Y; Hashimoto S; Narita M; Khotib J; Miyatake M; Sakurai T; Yanagisawa M; Nakamachi T; Shioda S; Suzuki T J Neurosci; 2006 Jan; 26(2):398-405. PubMed ID: 16407535 [TBL] [Abstract][Full Text] [Related]
22. μ-opioid receptors in the stimulation of mesolimbic dopamine activity by ethanol and morphine in Long-Evans rats: a delayed effect of ethanol. Valenta JP; Job MO; Mangieri RA; Schier CJ; Howard EC; Gonzales RA Psychopharmacology (Berl); 2013 Aug; 228(3):389-400. PubMed ID: 23503684 [TBL] [Abstract][Full Text] [Related]
23. Estrogen-dependent alterations in D2/D3-induced G protein activation in cocaine-sensitized female rats. Febo M; González-Rodríguez LA; Capó-Ramos DE; González-Segarra NY; Segarra AC J Neurochem; 2003 Jul; 86(2):405-12. PubMed ID: 12871581 [TBL] [Abstract][Full Text] [Related]
24. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238 [TBL] [Abstract][Full Text] [Related]
25. Anti-opioid effects of neuropeptide FF receptors in the ventral tegmental area. Kersanté F; Wang JY; Chen JC; Mollereau C; Zajac JM Neurosci Lett; 2011 Jan; 488(3):305-9. PubMed ID: 21111027 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of Cancer Pain and Medical Narcotics]. Suzuki T Yakugaku Zasshi; 2015; 135(12):1325-34. PubMed ID: 26632147 [TBL] [Abstract][Full Text] [Related]
27. (+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat. Terashvili M; Wu HE; Schwasinger ET; Hung KC; Hong JS; Tseng LF Eur J Pharmacol; 2008 Jun; 587(1-3):147-54. PubMed ID: 18448094 [TBL] [Abstract][Full Text] [Related]
28. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats. Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568 [TBL] [Abstract][Full Text] [Related]
29. Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system. Kawahara Y; Kaneko F; Yamada M; Kishikawa Y; Kawahara H; Nishi A Neuropharmacology; 2013 Apr; 67():395-402. PubMed ID: 23220294 [TBL] [Abstract][Full Text] [Related]
31. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350 [TBL] [Abstract][Full Text] [Related]
32. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. MacDonald AF; Billington CJ; Levine AS Brain Res; 2004 Aug; 1018(1):78-85. PubMed ID: 15262208 [TBL] [Abstract][Full Text] [Related]
33. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception. Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076 [TBL] [Abstract][Full Text] [Related]
34. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission. Yan QS; Zheng SZ; Feng MJ; Yan SE Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943 [TBL] [Abstract][Full Text] [Related]
36. Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain. Selley DE; Herbert JT; Morgan D; Cook CD; Picker MJ; Sim-Selley LJ Brain Res Bull; 2003 May; 60(3):201-8. PubMed ID: 12754081 [TBL] [Abstract][Full Text] [Related]
37. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward. David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model. Wu Y; Na X; Zang Y; Cui Y; Xin W; Pang R; Zhou L; Wei X; Li Y; Liu X Biochem Biophys Res Commun; 2014 Jul; 449(4):502-7. PubMed ID: 24845379 [TBL] [Abstract][Full Text] [Related]
39. GABAA receptors in VTA mediate the morphine-induced release of ascorbic acid in rat nucleus accumbens. Sun JY; Yang JY; Wang F; Hou Y; Dong YX; Wu CF Brain Res; 2011 Jan; 1368():52-8. PubMed ID: 20965157 [TBL] [Abstract][Full Text] [Related]
40. Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area. Rahman S; McBride WJ J Neurochem; 2002 Feb; 80(4):646-54. PubMed ID: 11841572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]